AVANOS MEDICAL INC (AVNS)
US05350V1061 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 87.70M | 127.70M | 118.50M | 111.50M | 205.30M | |||
| Receivables | 142.80M | 167.90M | 131.20M | 167.90M | 163.80M | |||
| Inventories | 163.20M | 190.30M | 159.30M | 168.90M | 145.90M | |||
| Other Current Assets | 93.30M | 13.90M | 18.60M | 18.90M | 23.50M | |||
| Total Current Assets | 487.00M | 499.80M | 427.60M | 467.20M | 538.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 144.00M | 194.50M | 206.70M | 223.60M | 248.50M | |||
| Goodwill | 796.10M | 819.40M | 801.60M | 802.50M | 800.90M | |||
| Intangibles | 239.50M | 251.00M | 141.20M | 157.70M | 184.30M | |||
| Other Non-Current Assets | 25.80M | 22.20M | 26.50M | 21.80M | 27.40M | |||
| Total Non-Current Assets | 1.21B | 1.29B | 1.18B | 1.21B | 1.26B | |||
| TOTAL ASSETS | 1.69B | 1.79B | 1.60B | 1.67B | 1.80B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 8.60M | 6.20M | 0.00 | N/A | N/A | |||
| Accrued Expenses | 106.00M | 111.70M | 82.80M | 98.70M | 129.50M | |||
| Accounts Payable | 56.30M | 67.90M | 56.40M | 67.60M | 83.00M | |||
| Other Current Liabilities | 63.70M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 234.60M | 185.80M | 139.20M | 166.30M | 212.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 159.40M | 226.30M | 130.00M | 180.00M | 248.10M | |||
| Deferred Taxes/Income | 23.80M | 25.40M | 11.90M | 5.70M | 0.00 | |||
| Other Non-Current Liabilities | 38.30M | 58.20M | 51.90M | 64.30M | 73.80M | |||
| Total Non-Current Liabilities | 221.50M | 309.90M | 193.80M | 250.00M | 321.90M | |||
| TOTAL LIABILITIES | 456.10M | 495.70M | 333.00M | 416.30M | 534.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -314.90M | -253.10M | -303.60M | -315.50M | -288.30M | |||
| Additional Paid In Capital | 1.66B | 1.65B | 1.63B | 1.61B | 1.59B | |||
| Common Shares | 500.00K | 500.00K | 500.00K | 500.00K | 500.00K | |||
| Treasury Stock | -85.90M | -66.80M | -21.30M | -9.80M | -8.90M | |||
| Other Shareholders' Equity | 0.00 | 300.00K | 0.00 | -400.00K | -500.00K | |||
| Shares Outstanding | 46.17M | 46.50M | 48.20M | 47.90M | 47.70M | |||
| Tangible Book Value per Share | 4.35 | 4.75 | 6.80 | 6.19 | 5.87 | |||
| Total Shareholders' Equity | 1.24B | 1.29B | 1.27B | 1.26B | 1.27B | |||
| TOTAL LIABILITIES AND EQUITY | 1.69B | 1.79B | 1.60B | 1.67B | 1.80B | |||
| Statistics | ||||||||
| Debt/Equity | 0.13 | 0.18 | 0.10 | 0.14 | 0.20 | |||
| Current Ratio | 2.08 | 2.69 | 3.07 | 2.81 | 2.53 | |||
| Return On Assets (ROA) | -3.65% | 2.83% | 0.32% | -1.63% | -2.55% | |||
| Return On Equity (ROE) | -5.00% | 3.91% | 0.41% | -2.16% | -3.63% | |||
| Return On Invested Capital (ROIC) | 0.22% | 3.68% | 0.88% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 0.24% | 4.00% | 0.96% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 0.97% | 14.61% | 3.21% | N/A | N/A | |||
All data in USD